Deeper and Early Molecular Response is a Good Predictor for Risk of Relapse in Patients with Acute Promyelocytic Leukemia
Background: Conventional treatment of acute promyelocytic leukemia (APL) including all-trans retinoic acid (ATRA) with anthracycline had led to good patient response and survival. However, instances of relapse continue to occur, and remain the major problem with this course of treatment. Patients an...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2015-06-01
|
| Series: | Journal of Cancer Research and Practice |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2311300616300696 |